Biodesix, Inc. (BDSX) vs MedX Health Corp. (MDXHF)

Biodesix, Inc. and MedX Health Corp. are both Diagnostics & Research companies. Biodesix, Inc. is the larger, with a market value of $310.2M against $103.2M — 3.0× the size. Biodesix, Inc. grew revenue faster over the last twelve months: 34.5% against 9.96%. Biodesix, Inc. has the higher net margin (−27.0% vs −1,095.0%) and the lower return on invested capital (−49.6% vs 0.00%). Across the 17 metrics below, Biodesix, Inc. leads on 14 and MedX Health Corp. on 3.

Valuation

Metric BDSX MDXHF Diagnostics & Research median
P/E n/m n/m 33.95
P/S 2.91 25.16 4.87
P/B 32.77 n/m 3.12
Price to free cash flow n/m n/m 34.02
EV/EBITDA n/m n/m 25.20
EV/Sales 3.07 30.65 5.66
Earnings yield (10.89%) (46.00%) (1.75%)
Free cash flow yield (6.81%) (55.11%) (0.13%)

Profitability

Metric BDSX MDXHF Diagnostics & Research median
Gross margin 82.50% (6.88%) 50.89%
Operating margin (20.02%) (742.33%) (8.57%)
Net margin (26.97%) (1,094.99%) (6.37%)
Free cash flow margin (19.82%) (999.18%) 0.00%
Return on equity (540.01%) 63.45% (2.92%)
Return on assets (30.33%) (867.29%) (6.71%)
Return on invested capital (49.60%) 0.00% 0.00%

Growth

Metric BDSX MDXHF Diagnostics & Research median
Revenue growth (TTM) 34.46% 9.96% 7.69%
EPS growth (last fiscal year) 29.24% (52.00%) —
Revenue growth, 5-year CAGR 14.20% (55.05%) 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BDSX MDXHF Diagnostics & Research median
Debt to equity 5.12 (0.32) 0.11
Current ratio 2.85 0.04 2.02
Net debt to EBITDA (1.36) (0.40) 0.78

Dividend

Metric BDSX MDXHF Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric BDSX MDXHF Diagnostics & Research median
Market cap 310.20m 103.16m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack